GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
23.59
-0.25 (-1.05%)
Sep 28, 2026, 1:59 PM EDT - Market open
GH Research Market Cap
GH Research has a market cap or net worth of $1.62 billion as of September 28, 2026. Its market cap has increased by 80.78% in one year.
Market Cap
1.62B
Enterprise Value
1.26B
1-Year Change
80.78%
Ranking
Category
Stock Price
$23.59
ChartMarket Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.62B, an increase of 100.32%. That is a compound annual growth rate of 14.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 1.62B | 105.55% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Septerna | 1.75B |
| Absci | 1.72B |
| Intellia Therapeutics | 1.67B |
| Hemab Therapeutics Holdings | 1.66B |
| Stoke Therapeutics | 1.65B |
| Nanobiotix | 1.61B |
| Syndax Pharmaceuticals | 1.61B |
| Rapport Therapeutics | 1.60B |